407 related articles for article (PubMed ID: 31006067)
1. Selective vulnerability in α-synucleinopathies.
Alegre-Abarrategui J; Brimblecombe KR; Roberts RF; Velentza-Almpani E; Tilley BS; Bengoa-Vergniory N; Proukakis C
Acta Neuropathol; 2019 Nov; 138(5):681-704. PubMed ID: 31006067
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V
Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766
[TBL] [Abstract][Full Text] [Related]
3. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG; Goedert M
Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
[TBL] [Abstract][Full Text] [Related]
4. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
5. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
6. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
Peelaerts W; Baekelandt V
J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies.
Javanshiri K; Drakenberg T; Haglund M; Englund E
J Parkinsons Dis; 2022; 12(4):1125-1131. PubMed ID: 35275559
[TBL] [Abstract][Full Text] [Related]
8. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
9. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
10. α-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases.
So RWL; Watts JC
J Mol Biol; 2023 Jun; 435(12):168011. PubMed ID: 36792008
[TBL] [Abstract][Full Text] [Related]
11. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
Henderson MX; Trojanowski JQ; Lee VM
Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
[TBL] [Abstract][Full Text] [Related]
12. Associations Between APOE Variants, Tau and α-Synuclein.
Rodriguez-Vieitez E; Nielsen HM
Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain.
Zhang S; Dauer K; Strohäker T; Tatenhorst L; Caldi Gomes L; Mayer S; Jung BC; Kim WS; Lee SJ; Becker S; Liesche-Starnecker F; Zweckstetter M; Lingor P
Brain Pathol; 2023 Sep; 33(5):e13196. PubMed ID: 37485772
[TBL] [Abstract][Full Text] [Related]
14. Structural and Functional Insights into α-Synuclein Fibril Polymorphism.
Mehra S; Gadhe L; Bera R; Sawner AS; Maji SK
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680054
[TBL] [Abstract][Full Text] [Related]
15. Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.
Rey NL; George S; Brundin P
Neuropathol Appl Neurobiol; 2016 Feb; 42(1):51-76. PubMed ID: 26666838
[TBL] [Abstract][Full Text] [Related]
16. Neuropathology underlying clinical variability in patients with synucleinopathies.
Halliday GM; Holton JL; Revesz T; Dickson DW
Acta Neuropathol; 2011 Aug; 122(2):187-204. PubMed ID: 21720849
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
[TBL] [Abstract][Full Text] [Related]
18. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
[TBL] [Abstract][Full Text] [Related]
19. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences.
Peelaerts W; Bousset L; Baekelandt V; Melki R
Cell Tissue Res; 2018 Jul; 373(1):195-212. PubMed ID: 29704213
[TBL] [Abstract][Full Text] [Related]
20. Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study.
Donadio V; Incensi A; El-Agnaf O; Rizzo G; Vaikath N; Del Sorbo F; Scaglione C; Capellari S; Elia A; Stanzani Maserati M; Pantieri R; Liguori R
Sci Rep; 2018 Sep; 8(1):14246. PubMed ID: 30250046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
